On May 06, 2016 17:34 (IST)
Sun Pharma Advanced Research Company (SPARC), the pharma research and drug discovery arm of Sun Pharma, on Friday reported a slight increase in its stand-alone net loss at Rs 9.58 crore for the quarter to March 2016.
On May 03, 2016 15:55 (IST)
Sun Pharmaceuticals Industries' shares fell nearly 4 per cent on Tuesday after its New York Stock Exchange-listed subsidiary Taro Pharmaceutical stopped commercial sales of Keveyis, a drug used in treatment of periodic paralysis.
On April 11, 2016 13:10 (IST)
Sun Pharma stock price rose by nearly 2 per cent on Monday as it received approval from the US health regulator USFDA for its non-steroid drug BromSite used to treat inflammation and prevent pain in patients undergoing cataract surgery.
On March 30, 2016 12:36 (IST)
Shares of Sun Pharma rose by nearly 3 per cent today as the drug major forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for $293 million (over Rs 1,940 crore).
On March 29, 2016 15:08 (IST)
Indian shares were little changed on Tuesday amid caution ahead of the expiry of monthly derivative contracts later this week and a speech from Federal Reserve Chair Janet Yellen later in the day.
On March 16, 2016 13:06 (IST)
Pharma stocks were under strong selling pressure for second consecutive day, weighed down by a weekend order from the government banning over 300 drugs.
On February 02, 2016 16:00 (IST)
UPL, Sun TV Network, MRPL, Jidal Steel, NALCO, Torrent Pharma, JSW Steel and Glenmark were among the losers from the mid-cap space, down 3-4.6 per cent each.
On January 10, 2016 13:52 (IST)
Overall weakness in the equity market dragged down the combined market valuation of nine of the top ten most valued Indian companies by a whopping Rs 78,511.56 crore for the week ended January 8.
On December 29, 2015 15:53 (IST)
Some amount of buying was visible in realty, pharma, media and infrastructure shares while mild selling pressure was seen in select metal, IT and banking stocks.
On December 28, 2015 14:28 (IST)
Sarvendra Srivastava, CMT-head technical research at Phisense.com, says the Nifty has managed to close above the important 7,850 levels in the holiday-shortened week (December 21-24) despite weak volumes.
On December 22, 2015 17:56 (IST)
Shares of Sun Pharma rebounded on Tuesday after slumping 4.5 per cent on Monday. Shares of India's biggest pharma company gained as much as 2 per cent today on value-buying at lower levels.
On December 21, 2015 12:36 (IST)
Shares in India's largest drugmaker, Sun Pharmaceutical Industries Ltd, skidded more than 7 percent on Monday after U.S. regulators warned of standards violations at a key plant in the latest blow to India's generic drug industry.
On December 21, 2015 16:02 (IST)
The Sensex rose 217 points to close at 25,736 and the 50-share Nifty advanced 72 points to settle at 7,834 on the back of gains in banking, metal and IT shares.
On December 21, 2015 15:40 (IST)
The US Food and Drug Administration's (US FDA) warning letter to Sun Pharma indicates the agency is dissatisfied with the remedial measures the company has implemented since last September, when the FDA first notified the company of its concerns after an inspection.
On December 15, 2015 19:24 (IST)
However, the company did not disclose the financial details of the transaction. Sun Pharma said impact of this development on its financials will be negligible.
On December 10, 2015 15:15 (IST)
Scientists at Weizmann Institute have developed a recombinant enzyme currently undergoing animal studies for indications of brain stroke and glioblastoma.
On December 07, 2015 16:19 (IST)
Sun Pharma shares have underperformed the broader Nifty in the last three months as the company is struggling with issues at its Halol manufacturing facility, Ranbaxy integration as well as pricing pressure in the United States, the company's largest market.
On December 04, 2015 12:47 (IST)
Drug major Sun Pharmaceutical Industries on Friday said one of its subsidiaries has received approval of the US Food and Drug Administration (FDA) to manufacture and market generic version of Novartis' Gleevec, used in treatment of cancer, in America.
On December 04, 2015 16:08 (IST)
Sun Pharma is expected to commercially launch the product on February 1, 2016. "Under the terms of a settlement agreement with Novartis, the Sun Pharma subsidiary is permitted to launch its version of generic Gleevec in the United States on February 1, 2016," the company said.
On November 26, 2015 17:35 (IST)
Shares of Sun Pharma surged as much as 4.5 per cent to Rs 739 after its US-listed subsidiary Taro decided not to proceed with investment in wind energy projects.